Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Category: Workers Comp

517 posts found

First-Time Generics Approved for Two Pain Medications

Generic versions of Ultram (tramadol hydrochloride) tablets and Dyloject (diclofenac sodium) injections have been approved by the FDA.
Read More

NCCI Examines Impact of the ODG Formulary in Arizona and Tennessee

While the utilization of opioids and other problematic drugs decreased, similar drops were seen in states without closed formularies.
Read More

Healthesystems Product Owner Receives IAIABC NextGen Award

Stephanie Arkelian has been recognized as a talented young professional making a positive impact on the workers’ comp industry.
Read More

New York City and Nevada Prohibit Hiring Discrimination for Positive Marijuana Tests

Beyond exceptions for safety or federal positions, employers cannot refuse employment for testing positive for marijuana in pre-employment drug screenings.
Read More

Marijuana Laws No Longer Thought to Reduce Opioid Overdose Deaths

A new study builds upon earlier research with a larger, more up-to-date dataset, finding a reversal in trends.
Read More

Healthesystems at WCI Orlando 2019

Visit Healthesystems in booth #909 and learn how we’re making waves in workers’ comp, and how we hope to benefit coastal cleanups for the “Coast to Coast” theme.
Read More

FDA Reexamines Discontinued Drug for New Pain Applications

Orphengesic Forte has received a decision date of August 14, 2019.
Read More

Shifting Gears in Patient Transportation with Rideshare

How services like Lyft and Uber can amplify injured worker transportation programs to improve claims outcomes.
Read More

The Growing Utilization and Costs of Anticancer Medications

Though they’re only needed for special cases in workers’ comp, anticancer medications can easily exceed $10,000 per monthly fill.
Read More

FDA Proposes Fixed-Quantity Blister Packaging for Certain Opioids

In a call for public comment, the FDA believes that reducing excess opioid supplies can lower opioid misuse, abuse, and overdose.
Read More

FDA Approves First Generic Naloxone Nasal Spray for Opioid Overdose

The life saving antidote for opioid overdose will soon be available in a consumer-friendly, generic nasal spray.
Read More

2019 Workers’ Comp Industry Insights Survey

Healthesystems partnered with Risk & Insurance magazine to survey 500+ work comp professionals on their top challenges, trends, successes, and more.
Read More

Negative Impacts of Combining Antidepressants with Opioids and Benzodiazepines

Combining all three drugs can reduce claim closure rates to 58.3%, with average claim costs of $94,000.
Read More

Growing Trend: Expanding Cancer Coverage for Firefighters

Florida enacted a law to cover 21 different cancers, while other states like Montana, Maryland, and Virginia have recently passed similar laws.
Read More

National Institute of Health to Launch $350 Million Opioid Intervention Study

Four research sites will test proven opioid prevention and treatment interventions, hoping to reduce overdose deaths by 40% over three years.
Read More
1 2 3 4 5 27 28 29 30 31 32 33 34 35
lockmap-markermagnifiercrossmenuarrow-rightcross-circle